APBI Journal Club PowerPoint
APBI Journal Club PowerPoint
APBI Journal Club PowerPoint
Partial Breast
Irradiation
PRESENTED BY REGAN HIME
Overview
What is APBI?
Why APBI?
APBI Phase III clinical trial results
What are the optimal candidate characteristics for APBI?
Treatment planning considerations
CT
Beam Arrangement
Setup imaging
Plan checks
Summary
I will be happy to take any questions at the end of the presentation
What is APBI?
Current gold standard for women with early-stage breast cancer is breast conservation therapy
in which the patient gets a lumpectomy and then receives whole breast irradiation (WBI).
APBI is an alternative to WBI, defined as “radiation of the site of excision and adjacent breast
tissue only…that uses fractions >1.8–2.0 Gy/d within <5–6 weeks”1.
Can be done through a variety of modalities including interstitial brachytherapy,
brachytherapy using balloon catheters, and external beam radiation therapy.
Interstitial Brachytherapy Brachytherapy using balloon catheters External Beam Radiation Therapy
Why APBI?
Breast cancer is the second most common non-skin cancer and 5th leading cause of death by
cancer.
Every one in eight women in the U.S. will be diagnosed with breast cancer.
Shorter courses predict women are more likely to follow through with treatment.
Accelerated treatment on a whole breast would cause unacceptable normal tissue toxicity.
Recurrence usually occurs local to the original disease.
In addition, APBI allows for cosmesis, organ sparing, and fewer later effects compared with
WBI.
Outcomes from Clinical Trials
One of the early Phase III clinical trials focused on 3D-CRT and excluded IMRT treatment
techniques for a total of 60 patients.
This trial used a dose fractionation scheme of a total dose of 38.5 Gy, 3.85 Gy/fraction at two
fractions a day >6 hrs apart to total 10 fractions in 5 days of treatment.
The study followed the NSABP/RTOP protocol for Phase III clinical trials.
The clinical trial’s results are summarized as follows:
At a median 15 month follow, 10% of patients developed moderate to severe late toxicity
25% of patients developed moderate-to-severe late subcutaneous fibrosis
25% of patients developed clinical evidence of fat necrosis
Cosmetic outcome was good to excellent in 81.7%, fair in 11.7%, and poor in 6.7% of patients
Outcomes from Clinical Trials
A more recent Phase III clinical trial compared APBI via IMRT treatment delivery with
conventional WBI for a total of 520 patients.
This study used a dose fractionation scheme of a total dose of 30 Gy, 6 Gy per fraction for a
total of 5 fractions delivered every other day
At a 10 year follow-up, the clinical trial’s results are summarized as follows:
No significant differences in Breast Cancer Specific Survival and Overall Survival between APBI and WBI
No significant differences in number of patients with second primary cancers
APBI resulted in significantly improved treatment-related acute and late adverse events
No significant difference in ipsilateral breast tumor recurrence
APBI cosmesis results were superior to WBI
Optimal Candidates
for APBI
ASTRO Task Force for APBI categorizes patients as suitable, cautionary, or unsuitable APBI
candidates.
Candidates falling in the suitable category have the following characteristics:
Over the age of 50
T1 primary cancers
20 mm or less at the widest part of the tumor
Negative nodes
Positive estrogen receptor status
Absence of lymphovascular space invasion
Widely negative margins
No multicentricity
CT-Sim
At CT-sim, ideal setup is arms up, using Vac-Lok
No breast board because of clearance issues
The CT should start at or above the mandible and extend several cm below the inframammary
fold (including the entire lung).
4D Chest or Chest protocol is used (0.2 cm slice thickness)
4D untagged images can be used for physician to evaluation Maximum Intensity Projection
(MIP) of tumor while drawing volume (physician preference).
If 4D scan is taken, free breathing scan is used for treatment planning, due to 4D scan
sometimes coming out grainy.
Contouring
Target
and OARs
Physician draws Op Bed based on images, clips, and scar
wire.
There are two ways to determine CTV and PTV from Op Bed:
1. CTV is a 1.5 cm margin around Op Bed, then bone lung, etc. are
removed to get final CTV. PTV is then 0.5 cm margin around
CTV.
2. CTV is a 1.0 cm margin around Op Bed, then bone lung, etc. are
remove to get final CTV. PTV is then 1.0 cm margin around CTV.
IMRT VMAT
On each side, start at about normal tangent, 20° 200° CW 50°
spacing between 3 beams 50° CCW 200°
Constraints
Typical prescription is
600 cGy x 5 fractions
every other day
Physics Checks
Contours are reviewed.
Dose constraints are reviewed.
Beam arrangement is reviewed.